drugset / Trial / NCT00002680

Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer

NCT00002680

Phase 2 Completed 40 enrolled Yale University
Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of sequential high-dose chemotherapy followed by peripheral stem cell transplantation in treating patients with metastatic breast cancer that is responding to chemotherapy.

Timeline

Start
1994-02
Primary completion
2000-12
Completion
2000-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified Intravenous
Subject Megestrol Acetate Other / unclassified Oral
Subject Melphalan Small molecule Intravenous
Subject Tamoxifen Small molecule Oral
Subject Thiotepa Other / unclassified Intravenous
Background filgrastim Protein / enzyme biologic Subcutaneous

Indications